Abstract:We tested the hypothesis that exogenous administration of the ET-1 precursor, bigET-1, would regulate adult rat ventricular myocyte (ARVM) contractility in a p38-mitogen activated protein kinase (p38-MAPK)-dependent mechanism during sepsis. Ventricular myocytes from adult rat hearts (both sham and septic) were stimulated to contract at 0.5 Hz and mechanical properties were evaluated using an IonOptix Myocam system. Immunoblot analysis was used to determine the phosphorylation of p38-MAPK and extracellular signal-regulated kinase 1/2 (ERK1/2). ARVMs were treated with vehicle, bigET-1 and inhibitors for 24 h and then subjected to functional and biochemical estimations. Septic ARVM displayed a distorted cell membrane and irregular network within the cells along with increased cell contractility as evidenced by elevated peak shortening (PS), maximal velocity of shortening (+dL/dt) and relengthening (−dL/dt) in comparison to sham ARVM. BigET-1 treatment caused ARVM enlargement in both sham and sepsis groups. BigET-1 (100 nM) produced an increase in ARVM contractility in sham group as compared to vehicle treatment. However, septic ARVM treated with bigET-1 exhibited unaltered ARVM contractility, and upregulated ETB receptors as compared to respective sham group. BigET-1 increased the concentration of ET-1 and upregulated phosphorylation of p38-MAPK but not of ERK1/2 in sham and septic ARVM. Furthermore, inhibition of p38-MAPK by SB203580 (10 μM) increased ARVM contractility in sham but not in sepsis group. BigET-1 reversed SB203580-induced increase in PS in sham group but accentuated it in sepsis group. BigET-1 also reversed SB203580-induced inhibition of p38-MAPK phosphorylation in sham but not in septic ARVM. SB203580 pretreatment followed by bigET-1 administration significantly decreased p38-MAPK phosphorylation and downregulated ETB receptor expression as compared to bigET-1 treatment per se in sepsis group but not in sham. We concluded that a bigET-1-induced non-responsive effect on septic ARVM contractile function could be due to upregulation of p38-MAPK phosphorylation and ETB receptor expression.

Involvement of ERK1/2 Pathway in Endothelin ET_(A) and ET_(B) Receptor-Mediated Contraction in Isolated Rat Mesenteric Artery

[ERK1/2 Pathway Involved in the Expression of ETB Receptors of the Culturing Smooth Muscle Cells of Rat Mesenteric Artery].

Vascular Endothelin ET(B) Receptor-Mediated Contraction Requires Phosphorylation of ERK1/2 Proteins.

Enhanced Transcription of Contractile 5-Hydroxytryptamine 2a Receptors Via Extracellular Signal-Regulated Kinase 1/2 after Organ Culture of Rat Mesenteric Artery

Rapid functional upregulation of vasocontractile endothelin ETB receptors in rat coronary arteries

ALTERATION IN CONTRACTILE RESPONSE TO NORADRENALINE,5-HYDROXYTRYPTAMINE, SARAFOTOXIN 6c, AND ANGIOTENSINⅡ IN RAT MESENTERIC ARTERY DURING ORGAN CULTURE

Minimally Modified LDL Upregulates Endothelin Type B Receptors in Rat Coronary Artery Via ERK1/2 MAPK and NF-κB Pathways

[Endothelin-Stimulated Proliferation of Thoracic Artery Smooth Muscle Cells Involves Activation of Mitogen-Activated Protein Kinase].

Up-Regulation Of Alpha(1a)-Adrenoceptors In Rat Mesenteric Artery Involves Intracellular Signal Pathways

Up-regulation of Contractile Endothelin Receptors by Airborne Fine Particulate Matter in Rat Mesenteric Arteries Via Activation of MAPK Pathway

Stimulating Endothelin-1 Synthesis and Secretion of Rat Aorta by Rat UrotensinⅡ

Transcriptional Up-Regulation In Expression Of 5-Hydroxytryptamine(2a) And Transcriptional Down-Regulation Of Angiotensin Ii Type 1 Receptors During Organ Culture Of Rat Mesenteric Artery

Minimally modified low-density lipoprotein upregulates the ET B and α 1 receptors in mouse mesenteric arteries in vivo by activating the PI3K/Akt pathway.

Tail Vein Injection of Mmldl Upregulates Mouse Mesenteric Artery ETB Receptors Via Activation of the ERK1/2 Pathway.

Effect of endothelin-1 on the proliferation and phenotypic transformation of vascular smooth muscle cells in rat

Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro.

INHIBITION OF SIGNAL TRANSDUCTION PATHWAYS OF ENDOTHELIN-1-INDUCED PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS BY NITRIC OXIDE

Bigendothelin-1 via p38-MAPK-dependent mechanism regulates adult rat ventricular myocyte contractility in sepsis.

Inhibitors of the MAPK/ NF-κB Pathway Attenuate the Upregulation of the ETB Receptor Mediated by High Glucose in Vascular Smooth Muscle Cells

Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression

Pathogenesis of cardiovascular disease: Regulation of extracellular signal-regulated kinase on angiotensin II-induced proliferation of vascular smooth muscle cells